Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens

Inclusion Criteria: * Sign Informed Consent Document. * Presbyopic and require a spectacle add of up to and including 3.00 diopters (D). * Currently wear soft contact lenses. * Willing and able to wear multifocal contact lenses in both eyes within the available range of powers for this trial and comply with the wearing and replacement schedule. * Manifest cylinder less than or equal to 1.00 D. * Able to achieve best corrected visual acuity (BCVA) of 20/25 or better (Snellen) in each eye at distance (as determined by manifest refraction). * Able to achieve distance visual acuity of 20/40 (Snellen) or better in each eye with study lenses and deem subjective vision as satisfactory at time of dispense. * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Any anterior segment infection, inflammation, disease, or abnormality that contraindicates contact lens wear within 6 months prior to enrollment. * Any use of systemic or ocular medications for which contact lens wear could be contraindicated. * History of corneal or refractive surgery. * Biomicroscopy findings greater than Grade 2 at baseline. * A pathologically dry eye that precludes contact lens wear. * Monocular (only one eye with functional vision). * Wear habitual contact lenses on an extended wear schedule (any number of nights of overnight wear on a regular basis). * History of intolerance or hypersensitivity to any component of the investigational products. * Concurrent participation in a contact lens or contact lens care product clinical trial or within the previous 30 days. * Eye injury or ocular or intra-ocular surgery within 6 months prior to enrollment. * Other protocol-defined exclusion criteria may apply.